Zogenix International Limited, Inc., a subsidiary of Zogenix

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Zogenix International Limited, Inc., a subsidiary of Zogenix sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials none currently recruiting 5 completed later-stage tilt upper quartile by trial count

Zogenix International Limited, Inc., a subsidiary of Zogenix: 6 sponsored US clinical trials, none currently recruiting.

Zogenix International Limited, Inc., a subsidiary of Zogenix sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 5 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dravet Syndrome, with 1 trials.

Upper-quartile sponsor footprint

Zogenix International Limited, Inc., a subsidiary of Zogenix sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

6 total, page 1 of 1

COMPLETED Phase 1

A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol

NCT03467113
COMPLETED Phase 3

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

NCT03355209
TERMINATED Phase 3

A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

NCT03299842
COMPLETED Phase 3

A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

NCT02926898
COMPLETED Phase 3

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

NCT02823145
COMPLETED Phase 3

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

NCT02682927

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 5

Therapeutic Areas

Dravet Syndrome 1
Lennox Gastaut Syndrome 1

How the Zogenix International Limited, Inc., a subsidiary of Zogenix archive is shaped

6 indexed studies, none listed as recruiting (0% open); 5 completed (83%).

Phase mix: 5 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Dravet Syndrome (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Zogenix International Limited, Inc., a subsidiary of Zogenix: archived-pipeline peers nationwide

Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Zogenix International Limited, Inc., a subsidiary of Zogenix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share Zogenix International Limited, Inc., a subsidiary of Zogenix23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan Branch10xBio22nd Century Group3-C Institute for Social Development3 Waves Wellness
Zogenix International Limited, Inc., a subsidiary of Zogenix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Zogenix International Limited, Inc., a subsidiary of Zogenix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Zogenix International Limited, Inc., a subsidiary of Zogenix page

6 registered trials is a research-attention snapshot, not an endorsement of Zogenix International Limited, Inc., a subsidiary of Zogenix or any single study.

  • None of Zogenix International Limited, Inc., a subsidiary of Zogenix's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Dravet Syndrome is the condition Zogenix International Limited, Inc., a subsidiary of Zogenix studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dravet Syndrome trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Zogenix International Limited, Inc., a subsidiary of Zogenix pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.